Prophylaxis against venous thromboembolism in acutely ill medical patients: An observational study

Pharmacotherapy

Volumn 26, Issue 8 I, 2006, Pages 1086-1090

  Peterman, Carla M ^a   Kolansky, Daniel M ^b   Spinler, Sarah A ^b,c,d  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF THE SCIENCES   (United States)

^d UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

Anticoagulation; Medical patients; Prophylaxis; Venous thromboembolism; VTE

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; HEPARIN; WARFARIN;

ACUTE DISEASE; ADULT; AGED; ANTICOAGULATION; BLEEDING; CLINICAL OBSERVATION; DRUG INDICATION; EPISTAXIS; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT CONTRAINDICATION; VENOUS THROMBOEMBOLISM;

ACADEMIC MEDICAL CENTERS; ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARRHYTHMIA; ARRHYTHMIAS, CARDIAC; ASTHMA; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART FAILURE; HEART FAILURE, CONGESTIVE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PENNSYLVANIA; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; STOCKINGS, COMPRESSION; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 33746748159     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.8.1086     Document Type: Review

References (13)

1. American Heart Association. Heart disease and stroke statistics: 2005 update. Dallas, TX: American Heart Association; 2005.
2. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:338S-400.
3. Cohen AT, Alikhan R, Arcelus JI, et al. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost 2005;94:750-9.
4. Rahim SA, Panju A, Pai M, Ginsbert J. Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review. Thromb Res 2003;111:215-19.
5. Ageno W, Squizzato A, Ambrosini F, et al. Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns. Haematologica 2003;87:746-50.
6. Dobesh PP, Stacy ZA. Effects of a clinical pharmacy education program on improvement in the quantity and quality of venous thromboembolism prophylaxis for medically ill patients. J Manag Care Pharm 2005;11(9):755-62.
7. Stark JE, Kilzer WJ. Venous thromboembolism prophylaxis in hospitalized medical patients. Ann Pharmacother 2004;38:36-40.
8. Goldhaber SZ, Tapson VF, and the DVT FREE Steering Committee. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis (DVT FREE). Am J Cardiol 2004;93:259-62.
9. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999;341:793-800.
10. Leizorovicz A, Cohen A, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 2004;110:874-9.
11. Kucher N, Koo S, Quiroz R, et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005;352:969-77.
12. Labarere J, Bosson JL, Brion JP, et al. Validation of a clinical guideline on prevention of venous thromboembolism n medical inpatients: a before-and-after study with systematic ultrasound examination. J Intern Med 2004;256(4):338-48.
13. National Quality Forum. National consensus standards for the prevention and care of deep vein thrombosis. Available from http://www.qualityforum.org/ txDVTprojectsummaryFinal.pdf. Accessed May 25, 2005.